PANAGORA ASSET MANAGEMENT INC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$126,000
-58.7%
25,324
+5.0%
0.00%
-50.0%
Q4 2020$305,000
+60.5%
24,113
+24.5%
0.00%
+100.0%
Q3 2020$190,000
-35.4%
19,362
-34.4%
0.00%
-50.0%
Q2 2020$294,000
-41.2%
29,525
-47.8%
0.00%
-50.0%
Q1 2020$500,000
-76.2%
56,564
-75.1%
0.00%
-60.0%
Q4 2019$2,098,000
+78.2%
227,400
+13.6%
0.01%
+100.0%
Q3 2019$1,177,000
-58.0%
200,209
-14.2%
0.01%
-61.5%
Q2 2019$2,800,000
+75.4%
233,344
+76.5%
0.01%
+85.7%
Q1 2019$1,596,000
+3.0%
132,192
+7.0%
0.01%0.0%
Q4 2018$1,550,000
-31.7%
123,505
-19.2%
0.01%
-22.2%
Q3 2018$2,268,000
-42.4%
152,818
-34.7%
0.01%
-43.8%
Q2 2018$3,940,000
+44.3%
234,106
+96.4%
0.02%
+45.5%
Q1 2018$2,730,000
+183.5%
119,201
+220.3%
0.01%
+175.0%
Q4 2017$963,000
+1560.3%
37,220
+1105.3%
0.00%
Q3 2015$58,000
-79.5%
3,088
-83.7%
0.00%
-100.0%
Q2 2015$283,000
-42.8%
19,003
-41.8%
0.00%
-66.7%
Q1 2015$495,00032,6580.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 968,198$9,634,0003.29%
INGALLS & SNYDER LLC 1,382,048$13,751,0000.79%
SPHERA FUNDS MANAGEMENT LTD. 700,710$6,972,0000.66%
Alambic Investment Management, L.P. 17,900$178,0000.45%
RA Capital Management 1,858,474$18,492,0000.36%
Perceptive Advisors 2,150,641$21,398,0000.35%
Eversept Partners, LP 232,983$2,318,1810.32%
GSA CAPITAL PARTNERS LLP 17,351$173,0000.10%
Alyeska Investment Group, L.P. 502,783$5,003,0000.08%
KENNEDY CAPITAL MANAGEMENT LLC 263,958$2,626,0000.08%
View complete list of CONCERT PHARMACEUTICALS INC shareholders